By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ImmunoGen, Inc. 

128 Sidney Street

Cambridge  Massachusetts  02139-4239  U.S.A.
Phone: 617-995-2500 Fax: 617-995-2510


SEARCH JOBS




Collaborations

GlaxoSmithKline (North Carolina) 

Raven Biotechnologies, Inc.  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.

Medarex, Inc.  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.





Company News
ImmunoGen (IMGN) Announces Clinical Data Presentations At Upcoming ASCO Annual Meeting 5/14/2015 12:20:00 PM
ImmunoGen (IMGN) Announces Webcast Of Presentations At Upcoming Investor Conferences 5/4/2015 11:27:15 AM
ImmunoGen (IMGN) Has Good News, Bad News as Sanofi (SAN.PA) SAAR3419 Deal Falls Apart and Ovarian Cancer Treatment Moves Forward 4/28/2015 6:50:17 AM
ImmunoGen (IMGN) Reports Third Quarter Fiscal Year 2015 Financial Results 4/24/2015 7:48:33 AM
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C Represents ImmunoGen (IMGN) In $200 Million Transaction 4/15/2015 12:42:28 PM
ImmunoGen (IMGN) Announces Conference Call To Discuss Its Third Quarter Fiscal Year 2015 Financial Results 4/9/2015 9:47:35 AM
ImmunoGen (IMGN) Appoints Anna Berkenblit, MD, MMSc Vice President And Chief Medical Officer 4/1/2015 12:11:13 PM
ImmunoGen (IMGN) Announces $200 Million Non-Dilutive Royalty Transaction 3/30/2015 12:30:47 PM
ImmunoGen (IMGN) Jumps After Reaching $220 Million Cancer Deal With Takeda (TKPYY) 3/23/2015 6:18:00 AM
ImmunoGen, Inc. (IMGN) Announces Presentations At Upcoming American Association for Cancer Research Annual Meeting 2015 3/19/2015 10:52:21 AM
12345678910...
//-->